Outpatient Induction Chemotherapy in Treating Patients With Acute Myeloid Leukemia or Advanced Myelodysplastic Syndrome
Status:
Completed
Trial end date:
2020-01-08
Target enrollment:
Participant gender:
Summary
This pilot clinical trial studies the feasibility of having induction chemotherapy in an
outpatient setting. Patients with acute leukemia (AML) or advanced myelodysplastic syndrome
(MDS), at least 18 years of age will be examined. Treating eligible patients with induction
chemotherapy in an outpatient setting may save in healthcare cost and improve a patients'
quality of life.